PTC Therapeutics receives FDA approval for PKU treatment drug
Go back to PTC Therapeutics receives FDA approval for PKU treatment drug| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 70.61 +1.07 (1.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $69.54 | 52 Week High | $35.40 | |||
| Open | $69.42 | 52 Week Low | $4.03 | |||
| Day High | $70.84 | P/E | 7.51 | |||
| Day Low | $69.05 | EPS | $9.40 | |||
| Volume | 318,117 | |||||
